- Sildenafil Citrate (TP)
- Sildenafil Citrate TEVA
- Tadalafil TEVA
- Sildenafil Citrate (GS)
- Vardenafil TEVA
- Vardenafil ZYDUS
Original Paper Published by the Journal of Medical Internet Research
An International Scientific Journal for eHealth - Medical Research, Information and Communication on the Internet
Internet-based Prescription of Sildenafil: A 2104-Patient Series
by: Miles Jones MD
Background: The Internet is becoming increasingly important as a way for patients to acquire medical information and as a means for patient-physician communication. Questions about appropriate use of this new technology have been brought to the fore by the many patients using the Internet to seek sildenafil prescriptions.
Objective: To present the first description of a physician designed and directed Internet-based prescribing system of sildenafil, together with data covering more than 2,100 patient encounters.
Methods: Retrospective analysis of a large case series from a medical practice that prescribes sildenafil based on medical and sexual histories obtained through a physician designed and directed World Wide Web (WWW) site, compared against patients from clinics at a Midwestern inner city medical center. We compared all 2,104 Internet patients seeking sildenafil prescriptions online between June 14, 1998, and March 1, 1999, with all 36 medical center patients obtaining sildenafil prescriptions during the same period.
The outcome measures compared were: completeness of medical record; patient safety as noted by the follow up responses of all patients requesting refills, any comments received by the internet site (webmaster), and patient or physician comments noted in the clinic medical record; satisfaction as noted by the follow up responses of all patients requesting refills, any comments received by the internet site (webmaster), and patient or physician comments noted in the clinic medical record; examinations and laboratory tests.
Results: Fifty-six percent of Internet requests came from 46 states, and 44% from eight foreign countries. Of 2,104 requests, 2,100 were granted. Three hundred ten patients have requested medication refills: all reported erections sufficient for intercourse and 69% said their satisfaction exceeded all expectations; none were at all dissatisfied. Side effect rates were comparable to those in the literature. Comparison of the medical history obtained from Internet patients with that recorded in clinic patients' charts revealed that the former was far more complete. No clinic patient received any examination or laboratory test specific for erectile dysfunction or its causes. There were no reported deaths or serious complications in either group.
Conclusions: Internet-based prescription of sildenafil provides the physician with a complete and very detailed medical and sexual history for 100% of patients without denying any information routinely obtained in a direct patient contact setting. Internet-based practice, which may be expected to require far fewer healthcare resources than traditional settings, rates very high in patient satisfaction among patients requesting a refill; no negative comments were received from all other patients. Overall, these data support the safety and effectiveness of Internet prescribing of selected medications. KEYWORDS Impotence; Medical History Taking; Prescriptions, Drug; Questionnaires; Internet; Commerce; Quality of Health Care; Side Effects; Sildenafil; Physician-Patient Relations.
Erectile dysfunction is an extremely common condition: according to the Massachusetts Male Aging Study, 52% of surveyed men aged 40 to 70 had some degree of erectile dysfunction, with dysfunction being moderate to complete in approximately half of the 70-year-old men. Similarly, the National Health and Social Life Survey found erectile dysfunction reported by 18% of men aged 50 to 59 (the oldest group surveyed). Until recently, the condition was often ignored. This reflected both the mistaken perception that nothing practical could be done, and the understandable discomfort of many patients and healthcare providers in openly and frankly discussing sexual matters. This changed dramatically with the March 1998 approval of sildenafil (Viagra, Pfizer), the first effective oral medication for treatment of erectile dysfunction. Within two weeks, newspapers reported physicians were writing 15,000 to 20,000 prescriptions a day for the medication. Erectile dysfunction had graduated from secret shame to headline news. Even with erectile dysfunction on the front pages, many men continue to feel uncomfortable discussing their own conditions face-to-face with a health-care provider. At the same time, many patients are turning to the Internet for medical information and advice on a wide variety of conditions, often because they find the relative anonymity of the Internet less intimidating than a traditional office-based consultation. Their Internet usage may take the form of formal physician consultation; informal physician-originated information and advice; or information, advice, and support from others with similar conditions. This combination of circumstances suggests the Internet as a natural resource for addressing the needs of men with erectile dysfunction who may be reluctant to seek help from their regular physicians. To meet this need, the NET Doctor Group (an association of physicians, pharmacists, and information specialists) established an Internet-based system to provide information on erectile dysfunction and its treatment with sildenafil; to obtain the medical histories of patients with this condition, when appropriate and desired by the patient; and to prescribe sildenafil and, if requested, dispense it through an independent licensed pharmacy. We report on the first 2,104 patients to request sildenafil prescriptions, together with a comparison group of patients who received sildenafil prescriptions in a traditional medical practice (inner city teaching hospital clinic) setting, during the same 10.5 month period.
NetDr International Ltd. is a private company that uses a physician-designed World Wide Web (WWW) site (http://www.netdr.com) to collect patient information and medical history relevant to prescription of sildenafil. Physicians associated with but not employed by the Net Doctor International Ltd.review the provided medical history, on a fee-for-service basis (the fee is waived if the requested prescription is refused). All physicians are United States educated and trained, hold active license in multiple states, have current DEA registrations, practice independently of the Net Doctor International Ltd., provide full licensure and identification information to dispensing pharmacies, and maintain individual professional liability insurance. The physicians also attempt to make telephone contact with all patients requesting sildenafil prescriptions; such contact is required when the submitted information appears contradictory or otherwise inadequate to support a decision. Requests are typically approved or refused within 24 hours of submission. U.S. patients who are approved for sildenafil prescription have a choice of receiving the medication directly from the Net Doctor International Ltd.'s independent pharmacy (not owned or operated by the Net Doctor International Ltd.), or of having the prescription faxed to their usual pharmacy. Non-U.S. patients receive the medication directly from the Net Doctor International Ltd.. All prescriptions are written for 100-mg tablets of sildenafil as follows: Use 1/2 tab po at least 30 min. before anticipated intercourse (may need to take up to 2 hours before intercourse for maximal effect). If effect inadequate try 1 tab po as above. Warning: Do not take more than 1 tab/day. If unusual pain or symptoms occur consult physician. If chest pain occurs report immediately to nearest ER. For unusual pain or symptoms, patients are advised to consult a physician. Patients are free to contact any physician, including the Net Doctor International Ltd. associated physicians, at any time. The patient insert (see Figure 2a) advises the patient to consult his or her personal physician. For the most severe and life threatening reactions associated with vigorous or infrequent sexual activity, patients are unequivocally advised to report immediately to the nearest ER. The patient informational insert developed specifically for the Net Doctor International Ltd.'s patients and included with directly dispensed medication is shown in Figure 2a. The patient information sheet used by the private pharmacy for its non-Net Doctor International Ltd. clients is shown in Figure 2b. The typical prescription written for non-Net Doctor International Ltd. patients is for 25 mg sildenafil and reads as follows: Take as directed.
PatientsThis study includes all patients of the Net Doctor International Ltd. who requested prescriptions for sildenafil during the period from the opening of the Web site on June 14, 1998, to March 1, 1999. All patients acknowledged a waiver of liability and agreed to specific terms of comprehension and truthfulness before submitting their request for physician consultation. The wavier applies to the Net Doctor International Ltd., and not the independent physicians associated with the Net Doctor International Ltd., as they are not employees of the Net Doctor International Ltd.. Each physician may rely on the patient's understanding of sildenafil and its potential complications, and the veracity of the patient's answers to the data collection device, as implied by the wavier. We informally compare these Internet patients to patients receiving sildenafil prescriptions at clinics of an inner city teaching hospital during the same period. We reviewed charts of these patients, most of whom had been seen on several occasions prior to prescription of sildenafil, for a period of up to one year prior to the prescribing visit and for all subsequent visits. This report covers information obtained from the medical records of all patients who received sildenafil prescriptions as a result of in-person clinic consultations. It should be noted that the clinics are part of an inner city teaching hospital that is a publicly owned and operated facility. Thus, most clinic patients are members of a lower socioeconomic group. Most patients of the hospital do not have the financial means to afford treatment for erectile dysfunction. The small number of patients (36) in the office-based comparison group is a reflection of the group's socioeconomic status.
Characteristics of patients receiving sildenafil prescriptions are reported in Table 1. During the period covered by this report, 2,104 patients requested sildenafil prescriptions at the Net Doctor International Ltd. Web site. These patients were somewhat younger than typical for men with erectile dysfunction (mean age 49.4 + 5.3 years, median age 45.9 years), possibly reflecting a lower rate of computer usage among the elderly. Diagnoses of hypertension were reported by 18%, of diabetes by 13%, and of atherosclerosis by 7%. Ten patients had been treated for prostate cancer and one had experienced a spinal cord injury. Approximately 33% of the patients said they smoked; very few reported more than social drinking, while an unusually high 86% reported exercising regularly.
About 95% of the patients said that their impotence had occurred gradually, and 97% that it involved an inability to maintain, rather than to achieve, an erection. Most said their penises were slightly firm but not self-supporting, although a significant minority reported hardness sufficient for sex despite decreased firmness. Eighty seven percent indicated that there were times they were not impotent. Significantly, almost 66% of the patients reported previously seeking treatment from other physicians for their erectile dysfunction. At least 75% of these men received only psychological counseling or reassurance, and almost none were satisfied with their previous treatment. Of the 2,104 requests for sildenafil, 2,100 were granted. The small number of refused requests may appear unusual. It must be remembered that patients requested sildenafil only after reading information on the drug and its contraindications and completing an extensive medical history form. Individuals with contraindications to sildenafil presumably did not complete and submit the form, and therefore do not appear in the database of patients requesting sildenafil. Three of the requests that were refused came from the same address, provided the same demographic information, and requested the maximum number of tablets (30) for a single prescription. Attempts to reach the requester or requesters by telephone were unavailing. The other patient whose request was refused reported having been diagnosed with stroke, hypertension, and angina, yet denied chest pain. Attempts to reach him by telephone were likewise unavailing. Attempts were made to contact all patients by telephone. Less than 10% of all patients had conversations with the consulting physician. Less than one dozen questions required a physician's response; all questions were answered by email within 24 hours. The questioning patients submitted no follow-up questions. There were 2,101 male patients and 3 female patients in the group. One of the female patients reported a complete absence of libido, which had been relieved by taking sildenafil. The second had experienced sexual dysfunction since her complete hysterectomy three years previously. The physician managing her case had recommended that she try sildenafil in addition to the estrogen-testosterone combination with which she was currently being treated. The third reported problems of sexual performance. She was prescribed 10 sildenafil tablets. Three hundred ten (14.76%) of the 2,100 patients requested refills during the study period and have filled out forms reporting their experiences with the drug (see Table 3). The number of patients granted refills at their pharmacies is unrecorded. All 310 reported improvement sufficient for them to resume sexual activity and to achieve penetration. Two hundred eighty seven reported that they almost always enjoyed successful sexual performance, with 16 claiming that their sexual performance was always successful and 7 stating that successful performance occurred occasionally. Two hundred fifteen said that their overall satisfaction exceeded all expectations, 76 that it met most expectations, and 19 that they were satisfied; none said that they were dissatisfied or somewhat dissatisfied. Reports of side effects listed in Table 3 were comparable to those from sildenafil clinical trials. Since data could be obtained only from patients requesting refills, however, the sample may not be fully representative. No patient has complained directly to the Net Doctor International Ltd. via its web site. All prescriptions list the name, address, and telephone number of the dispensing pharmacy. The name of the prescribing physician is included on each prescription and the dispensing pharmacy has the physician's DEA number, state license, office address, and telephone numbers. No pharmacy has contacted the Net Doctor International Ltd. or its associated physicians concerning patient complaints. During this same period, 36 patients obtained sildenafil prescriptions from the hospital clinics. The type of medical information contained in the office-based group's charts is summarized in Table 2. These patients' medical records generally showed that blood pressure and pulse rate had been recorded at least once during the previous six months (including the index visit). Twenty of the 36 patients had received a general physical examination during that period, but only 6 had had their height and weight recorded and there was no record that any had received a rectal examination. Eight clinic patients were recorded as stating that their sex lives were poor and 4 as saying that there were times they were not impotent; these items were not recorded on any of the other reviewed charts. No chart contained any statement as to the quality of the patient's erection or whether the onset of erectile dysfunction was gradual or sudden. Likewise, no chart recorded either a blood lipid profile or any laboratory test relevant to diabetes. The only medical conditions of note recorded in these patients' charts were 4 instances of hypertension and 1 cerebrovascular accident. Just 16 of the 36 charts included a complete list of medications being taken by the patient. Since the primary contraindications to sildenafil use are certain concurrent medications, this is a significant omission. No deaths or serious complications among patients using sildenafil have been reported to the Net Doctor International Ltd., its associated private physicians or independent pharmacies by any patient; patient family member; attorneys representing the patient or their estate; or any local, state, or federal governmental agency. The medical records of the clinic patients had no indication of any adverse effects or death related to sildenafil usage. Lastly, FDA and Pfizer surveillance systems have not reported any deaths directly attributed to sildenafil. The possibility of unreported deaths or complications cannot be completely ruled out
The explosive popularity of sildenafil, and the demonstrated desire of many patients to obtain this medication without a face-to-face discussion of what they regard as intimate personal matters, has brought to the fore the simmering question of Internet-based medical advice and consultation. Concern has been expressed by the Food and Drug Administration, members of the American Medical Association's Council on Ethical and Judicial Affairs, and the vice president of the Federation of State Medical Boards. Yet sildenafil is only a small part of the changes currently in progress. At least two groups are offering fee-for-service Internet-based medical consultations on a wide variety of conditions and many other physicians find themselves responding to on-line requests for medical information and advice even when that is not their officially stated policy. Indeed, medical information on the Internet is proliferating so rapidly that it has been the subject of an official report from a panel convened by the U.S. Department of Health and Human Services. While this panel did not specifically address one-to-one communication between physicians and patients, it did note many of the benefits, such as greater willingness to engage in frank discussions about health status, behavioral risks, and fears and uncertainties. Advantages and problemsAdvantages of Internet-based patient-physician communication when real-time contact is not required include convenience for the patient and savings in both time and office resources for the physician. Perhaps most importantly, the computer interface greatly facilitates both obtaining and recording a complete medical history. This conclusion is supported by our comparison of medical history data from the Internet consultation form with that from the charts of clinic patients. Due to the limited number of patients and the limited clinical setting, our findings indicate the need for funding further study and comparisons of physician directed Internet prescribing versus traditional prescribing practice. One objection that has been raised to Internet-based consultation and prescribing is that, as with the Net Doctor International Ltd., there is generally no mechanism for providing a consultation report to the patient's primary care physician. Several points need to be made. One is that, even in the U.S., it cannot be assumed that all patients have a primary care physician. A second is that many patients — almost half of those seeking sildenafil prescriptions — are from outside the U.S.; they and their physicians may have very different expectations regarding consultation reports. Third and most significantly, a considerable fraction of the patients may have sought Internet-based consultation because they did not want their usual physician to know of their condition or of a specific sildenafil order. For example, they may not wish their wife to know of the order and may not fully trust the discretion of a physician who treats both family members. Although this is regrettable, respect for patient autonomy requires that there should be no attempt to contact the patient's primary care physician without the patient's explicit permission. This latter point is also relevant to the frequently expressed opinion that it is easier to assess a patient's truthfulness in a face-to-face encounter. We are dealing here with patients who have specifically chosen to seek a prescription from someone other than their usual physician. In the absence of an established relationship, mere physical propinquity would do little to assure a complete and truthful medical and sexual history. Indeed, the relative anonymity of the Internet may, in our opinion, well increase patient truthfulness and openness. Another objection sometimes raised is that Internet-based practices, including the one described here, may not specifically list the credentials of the associated physicians. However, while physicians reviewing the site might find such information reassuring, its usefulness to patients appears remote. With rare exceptions, very few patients either understand or utilize the data on physician credentials that are available to them. Rather, they typically base their initial choice of physician on friends' recommendations and on convenience. Those factors remain valid in the context of Internet-based prescribing. Can erectile dysfunction be managed online?Clearly, not every medical condition is appropriately managed by Internet encounters alone. Erectile dysfunction may be particularly prominent among the appropriate conditions. Although objective means exist for establishing the existence of erectile dysfunction and for distinguishing between organic and psychogenic causes, these tests are cumbersome and often omitted even from specialists' most comprehensive recommendations. Indeed, there appears to be little in the way of consensus as to what, if anything, beyond the medical history might be appropriate in the diagnostic work-up of erectile dysfunction. Recommendations that the physical examination focus on signs of vascular and neurologic disease, together with palpation of the penis for Peyronie's disease and tests for atrophy are common. Except for detection of Peyronie's disease, which can usually be elicited by a thorough medical history, these observations are directed primarily toward determining a cause for the dysfunction. Prior to advent of sildenafil, the etiology of erectile dysfunction rarely affected the choice of treatment. Consequently, Hakim and Goldstein limit their recommended physical examination to abnormal penile curvature and palpable corporal fibrosis. Vinik has noted that erectile dysfunction is often the presenting symptom of diabetes and is also a marker for development of generalized vascular disease and for myocardial infarction. Godschalk et al recommend inclusion of a hemoglobin A1c and a lipid profile in all work-ups for erectile dysfunction. Similarly, Mobley and Baum recommend assessment of sacral root function by means of a rectal examination that includes evaluation of the bulbocavernosus reflex and of sphincter tone. All three tests are absent from the recommended diagnostic work-ups of other experts. Significantly, we found no mention of them in the charts of any of the teaching hospital clinic patients who received a sildenafil prescription. One can conclude that there is an almost total absence of expert consensus as to the essential components of an erectile dysfunction work-up. The only area of agreement is the importance of a complete medical and sexual history. Our observations of practice in a Midwestern inner city teaching hospital clinic suggest that physicians in this setting rely primarily on the history in deciding whether a sildenafil prescription is appropriate. Yet we also find that the medical and sexual history they obtain is less complete than that obtained by the Net Doctor International Ltd.. Once the physician has concluded that a sildenafil prescription is appropriate, the next step is to instruct the patient in the medication's proper and safe use. Although it is extremely difficult to assess how well different physicians communicate such instructions to their patients, many observations suggest that physician-patient communication is often less than optimal. It would presumably follow that many patients do not understand the instructions they receive. When oral information is poorly expressed or poorly understood, the patient information sheet becomes critical. As a comparison of Figures 2a and 2b shows, the information sheet provided by the Net Doctor International Ltd. to its Internet patients is far more thorough and complete, and perhaps more comprehensible as well. Further, it is not the standard for pharmacists to provide a specific patient instruction sheet when dispensing sildenafil. Greater thoroughness may be particularly important given the intuitively plausible assumption that Internet users as a group are likely to grasp information more easily when it is presented in written rather than oral form. Are current ethical codes and legislation too restrictive?The American Medical Association has noted that: Telecommunications advisory services, by way of phone, fax, or computer, can be a helpful source of medical information for the public. Often people are not sure where to turn for information of a general medical nature or do not have easy access to other sources of information. Individuals may also be embarrassed about directly bringing up certain questions with their physicians. The statement goes on to say: "Under no circumstances should medications be prescribed." This dictum, which is currently being revised, appears unduly restrictive. It may derive from the belief that, without physical examination and laboratory tests, the etiologic basis of a patient's complaint cannot be identified. The point overlooked by this assumption is that sildenafil is only one of many medications intended, not to cure an etiology, but to relieve a symptom; symptoms are normally diagnosed solely on the basis of patient histories. The ease with which the appropriateness of certain medications may be assessed underlies the prescriptive authority sometimes granted pharmacists, who are highly expert in medications and their uses but have little or no diagnostic training. As of 1996, 16 states plus the Indian Health Service and the Department of Veterans Affairs allowed pharmacists to initiate or modify drug therapy under certain conditions; similar legislation was pending in 15 additional states. In almost all instances, this authority was gained with the acquiescence of organized physician groups. Support for pharmacists initiating drug therapy is greatest when the condition being treated is diagnostically obvious. A 1993 survey of New York State internists and family practitioners found that 64% of the physicians questioned supported pharmacists providing a butoconazole vaginal cream for candidiasis and 61% supported pharmacists providing a steroid-containing rectal suppository for hemorrhoid sufferers. Washington State allows certain pharmacists to directly dispense emergency contraceptives. And although Florida pharmacists are authorized to prescribe approximately 30 types of medication, 82% of their prescriptions fall into just three categories: topical pediculicides (lindane shampoos), oral analgesics, and otic analgesics. Neither physicians nor the Food and Drug Administration, which in recent years has approved the transfer of large numbers of formerly prescription-only drugs to nonprescription status, believe that every prescription drug calls for elaborate physician physical examination and history. The clinic records from the inner city teaching hospital we examined indicate that some believe sildenafil may belong in this category. It might well be argued that the only reason sildenafil requires a prescription is the need for monitoring of contradictions and potential drug interactions, plus the mistaken ideas many patients hold about its indications and proper usage. This study provides evidence that both monitoring and the provision of patient information can be performed via the Internet at least as well as, and perhaps better than, through a traditional face-to-face physician-patient interview. Cross-border issuesConcerns have been expressed about the potential availability to patients of drugs not yet approved in their countries of residence. That this is a very real possibility is shown by the experience of the Net Doctor International Ltd.: 44.4% of the sildenafil prescriptions were issued to patients in 8 different non-U.S. countries. The concern is not truly limited to Internet-based prescribing: many Canadians crossed the border to obtain sildenafil from U.S. pharmacies prior to the medication's availability in their own country. A large number of countries allow patients to import small amounts of nationally unapproved medications for their personal use. The question is whether individuals' increased ability to obtain nationally unapproved drugs without physically traveling outside their country of residence calls for changes in the law. ConclusionOur results support Internet-based prescription (IBP) of sildenafil utilizing a physician designed and controlled information and decision system. The Internet-based prescribing physician consistently has more, not less, clinically relevant and useful information than was typically obtained and utilized in a specific hospital clinic setting. The data suggest that contrary too conventional thought, there is no evidence of compromise to patient safety. This statement is made with the important limitation that our study utilized only passive means to document patient adverse reactions or complaints. Our web site is available for comments 24 hours a day every day of the year. No negative feedback from patients using sildenafil was noted. Established monitoring systems operated by the FDA, Pfizer, local and state governments are actively gathering data. As of the current date we have served over 5100 patients and have received only one complaint from a patient (the patient had a history of asthma and was distressed that he was granted a prescription, he had been advised by a physician "acquaintance" it was unsafe for him to use sildenafil). While our patients represent a minute proportion of all patients using sildenafil, we expect the aforementioned external event tracking systems would detect any significant variation in the expected outcomes of our patients. Based on the significant lack of spontaneous and voluntarily recorded complaints and the overwhelmingly positive comments of patients seeking refills, patients appear to be satisfied with our approach. IBP is associated with extremely low demands on health care resources and maximum responsiveness to patient needs. Health care standards and governmental regulatory efforts to date have not been based on objective or experimental evidence. They have significantly lagged behind the capabilities and implementation of Internet prescribing systems. We hope that data from this first large, objective scientific study can serve as a starting point for development of fact based, meaningful standards and regulations. We encourage further and broader evaluation of physician-designed and controlled Internet prescribing systems.
Acknowledgements: We thank W. A. Thomasson, PhD, for expert assistance in preparation of the manuscript.
Conflict of Interest: Miles Jones, MD serves as the medical director for Net Doctor International and owner of Consultative & Diagnostic Pathology, Inc. Consultative & Diagnostic Pathology receives compensation from Net Doctor International for each medical review provided by Dr. Jones. Dr. Jones personally owns 180 shares of Pfizer stock.
- Feldman HA, Goldstein I, Hatzichristou DG, Krause RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 Jan;151(1):54-61. [Medline]
- Laumann EO, Paik A, Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999 Feb 10;281(6):537-44. [Medline]
- Rodriguez A. Men clamoring to try out new impotence pill. Chicago Sun-Times. 1998 April 22; Sect. A:1 (col. 2).
- Brown EW. A subject men don't talk about - even to each other. Med Update. 1997 Feb;20(8):1.
- Ferguson T. Digital doctoring--opportunities and challenges in electronic patient-physician communication. JAMA. 1998 Oct 21;280(15):1361-2. [Medline]
- Expert medical advice online: MediXperts service offers consultations for $195. Internet Med: Crit Guide. 1998 Jan;3(1):1-3.
- CyberDocs provide diagnoses via chat room. Internet Med: Crit Guide. 1998 July;3(7):1,4.
- Seek and ye shall find: sites that provide advice and answers to users' medical questions. Internet Med: Crit Guide. 1998 Jan;3(1):5.
- Eysenbach G, Diepgen TL. Responses to unsolicited patient e-mail requests for medical advice on the World Wide Web. JAMA. 1998 Oct 21;280(15):1333-5. [Medline]
- Wingerson L, Simon K, Northup L, Restino A, eds. Patient resources on the Internet: 1997 guide for health care professionals. New York, NY: Faulkner & Gray; 1997.
- Pfizer, Inc. VIAGRA (sildenafil citrate) tablets. New York, NY: Pfizer; 1998
- Viagra's licence and the internet [editorial]. Lancet. 1998 Sep 5;352(9130):751. [Medline]
- Marwick C. Several groups attempting regulation of Internet Rx. JAMA. 1999 Mar 17;281(11):975-6. [Medline]
- Robinson TN, Patrick K, Eng TR, Gustafson D. An evidence-based approach to interactive health communication: a challenge to medicine in the information age. Science Panel on Interactive Communication and Health. JAMA. 1998 Oct 14;280(14):1264-9. [Medline]
- Henney JE, Shuren JE, Nightingale SL, McGinnis TJ. Internet purchase of prescription drugs: buyer beware. Ann Intern Med. 1999 Dec 7;131(11):861-2. [Medline]
- Armstrong K, Schwartz JS, Asch DA. Direct sale of sildenafil (Viagra) to consumers over the Internet. N Engl J Med. 1999 Oct 28;341(18):1389-92. [Medline]
- Bloom BS, Iannacone RC. Internet availability of prescription pharmaceuticals to the public. Ann Intern Med. 1999 Dec 7;131(11):830-3. [Medline]
- Sanders CS. New treatments for erectile dysfunction. Patient Care. 1998 Mar 15:(5);30-32,35,39-40, 42,45-46,51-52.
- Finkbeiner A. Random musing about a little blue pill. J Ark Med Soc. 1998 Aug;95(3):100-1. [Medline]
- Melman A. Evaluation and management of erectile dysfunction. Evaluation and management of erectile dysfunction. Surg Clin North Am. 1988 Oct;68(5):965-81. [Medline]
- Padma NH. Neurologic evaluation of erectile dysfunction. Urol Clin North Am. 1988;15;77-80.
- Devine CJ, Horton CE. Peyronie's disease. Clin Plast Surg. 1988 Jul;15(3):405-9. [Medline]
- Godschalk MF, Sison A, Mulligan T. Management of erectile dysfunction by the geriatrician. J Am Geriatr Soc. 1997 Oct;45(10):1240-6. [Medline]
- Knispel HH, Huland H. Influence of cause on choice of therapy in 174 patients with erectile dysfunction. J Urol. 1992 May;147(5):1274-6.[Medline]
- Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrinol Metab Clin North Am. 1996 Jun;25(2):379-400. [Medline]
- Vinik A. Erectile dysfunction in diabetes: pills for penile failure. Clinical Diabetes. 1998;16:108-119.
- Mobley DF, Baum N. When patients request the impotence pill. Postgrad Med. 1998 Aug;104(2):55-8, 61-2, 65-6. [Medline]
- Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995 May 1;152(9):1423-33. [Medline]
- American Medical Association. Current Ethical Opinions: E-5.025 Physician Advisory or Referral Services by Telecommunications. Chicago: The Association, 1996:A-98.
- Shefcheck SL, Thomas J 3rd. The outlook for pharmacist initiation and modification of drug therapy. J Am Pharm Assoc. 1996;NS36:597-604.
- Wittenburg AS. Obtaining prescribing authority for pharmacists: lessons learned. Am J Health Syst Pharm. 1995 Aug 1;52(15):1616, 1620, 1623-4. [Medline]
- Bailie GR, Romeo B. New York State primary care physicians' attitudes to community pharmacists' clinical services. Arch Intern Med. 1996 Jul 8;156(13):1437-41. [Medline]
- Hutchings J, Winkler JL, Fuller TS, et al. When the morning after is Sunday: pharmacist prescribing of emergency contraceptive pills. J Am Med Womens Assoc. 1998;53(5 Suppl 2):230-2. [Medline]
- Eng HJ, McCormick WC. Assessment of the Florida Pharmacist Self-Care Consultant Law using patient profile and prescription audit methods. DICP. 1990 Oct;24(10):931-5. [Medline]
- Jacobs LR. Prescription to over-the-counter drug reclassification. Am Fam Physician. 1998 May 1;57(9):2209-14. [Medline]
- Sibbald B. Take care when prescribing new drug to treat impotence, MDs warned. CMAJ. 1998 Jun 30;158(13):1755-6. [Medline]
Submitted 11.09.00, peer-reviewed by John Grohol, reviewers comments to author 18.01.01, accepted 18.01.01, published 31.01.01. Please cite as: